For nearly a century, Lubrizol has created extraordinary value at the intersection of life and science, delivering sustainable solutions that advance mobility, improve well-being and enhance modern ...
Study represents the first clinical application of CMND-100, the Company’s proprietary drug platform Vancouver, Canada, March 18, 2025 (GLOBE ...
WASHINGTON, March 18, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced Dr. Mehmet Ekmekci has affiliated with the firm’s Compass Lexecon subsidiary.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback